Publications by authors named "N Rhyman"

Background: Patients with chronic lung disease (CLD), such as asthma or chronic obstructive pulmonary disease, were expected to have an increased risk of clinical manifestations and severity of COVID-19. However, these comorbidities have been reported less frequently than expected. Chronic treatment with inhaled corticosteroids (ICS) may impact the clinical course of COVID-19.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed COVID-19 hospital admissions from 2020 in Spain, focusing on older patients during two pandemic waves, to evaluate mortality differences.
  • Results showed a mortality rate of 20.4% during the first wave and 17.2% during the second wave, particularly among patients aged 70 and older, who had a significant mortality reduction of 7.6%.
  • The lower mortality in the second wave may be due to improved healthcare standards, greater clinical experience, or less strain on the healthcare system, independent of patient or disease severity.
View Article and Find Full Text PDF

Background: COVID-19 shows different clinical and pathophysiological stages over time. Theeffect of days elapsed from the onset of symptoms (DEOS) to hospitalization on COVID-19prognostic factors remains uncertain. We analyzed the impact on mortality of DEOS to hospital-ization and how other independent prognostic factors perform when taking this time elapsedinto account.

View Article and Find Full Text PDF

Background: COVID-19 shows different clinical and pathophysiological stages over time. The effect of days elapsed from the onset of symptoms (DEOS) to hospitalization on COVID-19 prognostic factors remains uncertain. We analyzed the impact on mortality of DEOS to hospitalization and how other independent prognostic factors perform when taking this time elapsed into account.

View Article and Find Full Text PDF

Objective: To determine the health status and exercise capacity of COVID-19 survivors one year after hospital discharge.

Methods: This multicenter prospective study included COVID-19 survivors 12 months after hospital discharge. Participants were randomly selected from a large cohort of COVID-19 patients who had been hospitalized until 15th April 2020.

View Article and Find Full Text PDF